Alexei Basnakian
Concepts (337)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deoxyribonuclease I | 11 | 2020 | 41 | 4.160 |
Why?
| Endodeoxyribonucleases | 11 | 2021 | 55 | 3.440 |
Why?
| DNA Fragmentation | 12 | 2021 | 67 | 3.020 |
Why?
| Lipoproteins, LDL | 13 | 2014 | 195 | 2.740 |
Why?
| Apoptosis | 16 | 2021 | 1306 | 2.710 |
Why?
| Kidney Tubules | 7 | 2020 | 100 | 2.050 |
Why?
| Epithelial Cells | 7 | 2020 | 256 | 1.840 |
Why?
| Atherosclerosis | 8 | 2015 | 253 | 1.490 |
Why?
| Kidney Diseases | 4 | 2021 | 292 | 1.380 |
Why?
| In Situ Nick-End Labeling | 5 | 2021 | 64 | 1.180 |
Why?
| Endothelium, Vascular | 4 | 2014 | 293 | 0.980 |
Why?
| Oxidative Stress | 6 | 2021 | 953 | 0.970 |
Why?
| Animals | 42 | 2022 | 14435 | 0.960 |
Why?
| Deoxyribonucleases | 3 | 2021 | 24 | 0.930 |
Why?
| DNA Topoisomerases | 1 | 2021 | 3 | 0.820 |
Why?
| DNA Breaks | 1 | 2020 | 4 | 0.790 |
Why?
| DNA | 5 | 2020 | 582 | 0.770 |
Why?
| Enzyme Inhibitors | 5 | 2017 | 456 | 0.760 |
Why?
| Kidney | 6 | 2021 | 828 | 0.750 |
Why?
| Cell Line | 10 | 2021 | 1166 | 0.740 |
Why?
| DNA Damage | 3 | 2021 | 358 | 0.740 |
Why?
| DNA Repair | 1 | 2021 | 201 | 0.730 |
Why?
| Endothelial Cells | 4 | 2010 | 296 | 0.700 |
Why?
| Cisplatin | 5 | 2014 | 354 | 0.690 |
Why?
| Cells, Cultured | 12 | 2021 | 1755 | 0.670 |
Why?
| Rats | 13 | 2020 | 3435 | 0.660 |
Why?
| Chromatin | 3 | 2007 | 155 | 0.620 |
Why?
| Small Molecule Libraries | 2 | 2014 | 72 | 0.620 |
Why?
| Graphite | 1 | 2017 | 31 | 0.590 |
Why?
| Antineoplastic Agents | 4 | 2014 | 1295 | 0.540 |
Why?
| Nanoparticles | 1 | 2017 | 172 | 0.530 |
Why?
| Intercellular Adhesion Molecule-1 | 4 | 2020 | 75 | 0.520 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 209 | 0.520 |
Why?
| Enzyme Assays | 1 | 2014 | 12 | 0.510 |
Why?
| High-Throughput Screening Assays | 1 | 2014 | 37 | 0.510 |
Why?
| Uremia | 2 | 2010 | 17 | 0.480 |
Why?
| Mice | 19 | 2022 | 6436 | 0.480 |
Why?
| Macrophages | 2 | 2014 | 401 | 0.480 |
Why?
| Carbamates | 1 | 2013 | 21 | 0.470 |
Why?
| Acetylcysteine | 2 | 2013 | 118 | 0.470 |
Why?
| Organ Preservation | 1 | 2013 | 16 | 0.470 |
Why?
| Monocytes | 3 | 2010 | 156 | 0.450 |
Why?
| Mice, Knockout | 9 | 2021 | 941 | 0.420 |
Why?
| Cell Death | 6 | 2015 | 228 | 0.410 |
Why?
| Endonucleases | 4 | 2021 | 19 | 0.390 |
Why?
| Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 42 | 0.380 |
Why?
| Nucleic Acids | 1 | 2009 | 13 | 0.360 |
Why?
| Receptors, Scavenger | 1 | 2009 | 28 | 0.360 |
Why?
| Gamma Rays | 1 | 2009 | 58 | 0.350 |
Why?
| Enzyme Activation | 5 | 2015 | 333 | 0.340 |
Why?
| DNA Methylation | 2 | 2014 | 575 | 0.330 |
Why?
| Humans | 31 | 2022 | 54132 | 0.330 |
Why?
| Nerve Growth Factors | 1 | 2008 | 31 | 0.320 |
Why?
| Cadmium Chloride | 1 | 2007 | 5 | 0.310 |
Why?
| DNA Replication | 2 | 2009 | 153 | 0.300 |
Why?
| Tumor Suppressor Proteins | 1 | 2008 | 141 | 0.300 |
Why?
| Drosophila melanogaster | 1 | 2007 | 23 | 0.300 |
Why?
| Chromosomes | 2 | 2006 | 37 | 0.300 |
Why?
| Cell Nucleus | 2 | 2007 | 205 | 0.300 |
Why?
| B-Lymphocytes | 1 | 2007 | 176 | 0.280 |
Why?
| Mammals | 1 | 2006 | 56 | 0.280 |
Why?
| Cell Line, Tumor | 6 | 2022 | 1542 | 0.280 |
Why?
| Acute Kidney Injury | 2 | 2008 | 404 | 0.270 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 526 | 0.270 |
Why?
| Cell Movement | 1 | 2006 | 276 | 0.270 |
Why?
| RNA, Messenger | 2 | 2015 | 1222 | 0.260 |
Why?
| Ischemia | 2 | 2004 | 175 | 0.250 |
Why?
| Oxidoreductases | 1 | 2004 | 64 | 0.250 |
Why?
| Coronary Vessels | 5 | 2011 | 197 | 0.250 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 411 | 0.250 |
Why?
| Cell Adhesion | 3 | 2010 | 171 | 0.250 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 318 | 0.240 |
Why?
| Reperfusion Injury | 2 | 2002 | 119 | 0.240 |
Why?
| Disease Models, Animal | 7 | 2022 | 1645 | 0.240 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 867 | 0.240 |
Why?
| Dose-Response Relationship, Drug | 3 | 2017 | 1478 | 0.240 |
Why?
| Signal Transduction | 6 | 2021 | 1754 | 0.230 |
Why?
| Oncolytic Virotherapy | 1 | 2022 | 18 | 0.220 |
Why?
| Kidney Failure, Chronic | 4 | 2012 | 229 | 0.220 |
Why?
| Kidney Cortex | 1 | 2002 | 39 | 0.210 |
Why?
| Acute Radiation Syndrome | 1 | 2022 | 23 | 0.210 |
Why?
| Muscle, Smooth, Vascular | 3 | 2008 | 144 | 0.210 |
Why?
| Breast Neoplasms | 2 | 2014 | 1248 | 0.210 |
Why?
| Alternative Splicing | 1 | 2002 | 63 | 0.210 |
Why?
| Renal Circulation | 1 | 2002 | 82 | 0.210 |
Why?
| Nanotubes, Carbon | 1 | 2022 | 70 | 0.210 |
Why?
| Antioxidants | 2 | 2015 | 297 | 0.210 |
Why?
| Chromans | 1 | 2022 | 63 | 0.200 |
Why?
| Mice, Inbred C57BL | 4 | 2011 | 2021 | 0.200 |
Why?
| Vitamin E | 1 | 2022 | 108 | 0.200 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 682 | 0.190 |
Why?
| Radiation-Protective Agents | 1 | 2022 | 117 | 0.190 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2021 | 85 | 0.190 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2020 | 41 | 0.190 |
Why?
| Carcinoma, Hepatocellular | 1 | 2022 | 203 | 0.180 |
Why?
| Thrombomodulin | 1 | 2020 | 47 | 0.180 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2020 | 84 | 0.180 |
Why?
| Rats, Sprague-Dawley | 4 | 2013 | 1676 | 0.180 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 96 | 0.180 |
Why?
| Caspases | 3 | 2013 | 147 | 0.180 |
Why?
| Hydrazones | 1 | 2019 | 5 | 0.180 |
Why?
| Acinetobacter baumannii | 1 | 2019 | 9 | 0.180 |
Why?
| Cell Survival | 2 | 2014 | 661 | 0.180 |
Why?
| Urea | 2 | 2010 | 83 | 0.170 |
Why?
| Drug Resistance, Bacterial | 1 | 2019 | 81 | 0.170 |
Why?
| Autophagy | 1 | 2021 | 202 | 0.170 |
Why?
| Liver Neoplasms | 1 | 2022 | 353 | 0.160 |
Why?
| Flow Cytometry | 2 | 2015 | 548 | 0.160 |
Why?
| Molecular Structure | 2 | 2019 | 322 | 0.160 |
Why?
| RNA, Small Interfering | 2 | 2009 | 254 | 0.160 |
Why?
| Heme Oxygenase (Decyclizing) | 1 | 2017 | 7 | 0.150 |
Why?
| Etoposide | 2 | 2008 | 85 | 0.150 |
Why?
| Brain | 2 | 2017 | 1364 | 0.150 |
Why?
| Staphylococcus aureus | 2 | 2019 | 361 | 0.150 |
Why?
| Transfection | 2 | 2009 | 410 | 0.150 |
Why?
| Profilins | 1 | 2017 | 18 | 0.150 |
Why?
| Caspase 3 | 1 | 2017 | 136 | 0.150 |
Why?
| Microscopy, Fluorescence | 2 | 2009 | 196 | 0.150 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2017 | 53 | 0.150 |
Why?
| Risk Assessment | 2 | 2022 | 1363 | 0.140 |
Why?
| Mutation, Missense | 1 | 2017 | 117 | 0.140 |
Why?
| Spinal Cord | 1 | 2017 | 150 | 0.140 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 64 | 0.140 |
Why?
| Gene Knockout Techniques | 2 | 2021 | 45 | 0.140 |
Why?
| Time Factors | 2 | 2017 | 3223 | 0.140 |
Why?
| Cell Cycle | 2 | 2007 | 274 | 0.140 |
Why?
| Liver | 3 | 2021 | 1246 | 0.140 |
Why?
| Gold | 2 | 2014 | 164 | 0.130 |
Why?
| Cell Culture Techniques | 2 | 2007 | 112 | 0.130 |
Why?
| Adenylate Kinase | 1 | 2015 | 10 | 0.130 |
Why?
| Enzyme Activators | 1 | 2015 | 8 | 0.130 |
Why?
| Cyclophilins | 1 | 2015 | 13 | 0.130 |
Why?
| Immunoenzyme Techniques | 1 | 2015 | 165 | 0.130 |
Why?
| Taxoids | 1 | 2014 | 45 | 0.130 |
Why?
| Thiobarbiturates | 1 | 2014 | 23 | 0.130 |
Why?
| PPAR alpha | 1 | 2015 | 65 | 0.130 |
Why?
| Inhibitory Concentration 50 | 1 | 2014 | 81 | 0.130 |
Why?
| Drug Resistance | 1 | 2014 | 75 | 0.130 |
Why?
| Antibodies | 3 | 2014 | 177 | 0.130 |
Why?
| Male | 9 | 2013 | 27350 | 0.120 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 210 | 0.120 |
Why?
| Risk Factors | 4 | 2015 | 3936 | 0.120 |
Why?
| Substrate Specificity | 1 | 2014 | 208 | 0.120 |
Why?
| Cardiovascular Diseases | 2 | 2012 | 482 | 0.120 |
Why?
| Nanotubes | 1 | 2014 | 38 | 0.120 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 92 | 0.120 |
Why?
| Metformin | 1 | 2015 | 69 | 0.120 |
Why?
| Particulate Matter | 1 | 2014 | 55 | 0.120 |
Why?
| Silver | 1 | 2014 | 54 | 0.120 |
Why?
| Zinc Acetate | 1 | 2013 | 1 | 0.120 |
Why?
| Organ Preservation Solutions | 1 | 2013 | 4 | 0.120 |
Why?
| Refrigeration | 1 | 2013 | 4 | 0.120 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 136 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 1 | 2015 | 256 | 0.120 |
Why?
| Blotting, Western | 1 | 2015 | 685 | 0.120 |
Why?
| Neoplastic Cells, Circulating | 1 | 2014 | 93 | 0.110 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 816 | 0.110 |
Why?
| Dietary Fats | 2 | 2010 | 144 | 0.110 |
Why?
| Kinetics | 1 | 2014 | 693 | 0.110 |
Why?
| Mitochondrial Membrane Transport Proteins | 2 | 2015 | 24 | 0.110 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 25 | 0.110 |
Why?
| Carotenoids | 1 | 2012 | 46 | 0.110 |
Why?
| Cell Division | 3 | 2008 | 330 | 0.110 |
Why?
| Oxidation-Reduction | 1 | 2013 | 384 | 0.110 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2011 | 10 | 0.100 |
Why?
| Renal Insufficiency, Chronic | 1 | 2015 | 183 | 0.100 |
Why?
| Genital Diseases, Female | 1 | 2011 | 22 | 0.100 |
Why?
| Bacteremia | 1 | 2012 | 102 | 0.100 |
Why?
| Cell Proliferation | 3 | 2010 | 1099 | 0.100 |
Why?
| Uterus | 1 | 2011 | 99 | 0.100 |
Why?
| Liver Diseases, Alcoholic | 1 | 2010 | 35 | 0.100 |
Why?
| Chlamydia muridarum | 1 | 2011 | 53 | 0.100 |
Why?
| Reproducibility of Results | 1 | 2014 | 1307 | 0.100 |
Why?
| Renal Dialysis | 3 | 2012 | 191 | 0.100 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 399 | 0.090 |
Why?
| Apolipoproteins E | 1 | 2010 | 63 | 0.090 |
Why?
| Nephrectomy | 1 | 2010 | 93 | 0.090 |
Why?
| Salicylates | 1 | 2009 | 10 | 0.090 |
Why?
| Scavenger Receptors, Class F | 1 | 2009 | 3 | 0.090 |
Why?
| Chlamydia Infections | 1 | 2011 | 119 | 0.090 |
Why?
| Chelating Agents | 1 | 2009 | 28 | 0.090 |
Why?
| Cell Line, Transformed | 1 | 2009 | 88 | 0.090 |
Why?
| DNA Polymerase III | 1 | 2009 | 6 | 0.090 |
Why?
| Replication Protein C | 1 | 2009 | 5 | 0.090 |
Why?
| Replication Protein A | 1 | 2009 | 6 | 0.090 |
Why?
| Blood Proteins | 1 | 2010 | 101 | 0.090 |
Why?
| Jejunum | 1 | 2009 | 55 | 0.090 |
Why?
| Fatty Liver | 1 | 2010 | 130 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2009 | 110 | 0.090 |
Why?
| Inflammation | 1 | 2014 | 677 | 0.090 |
Why?
| Zinc | 1 | 2009 | 59 | 0.090 |
Why?
| Autoantibodies | 1 | 2010 | 128 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2009 | 198 | 0.090 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 82 | 0.090 |
Why?
| Staphylococcal Infections | 1 | 2012 | 300 | 0.090 |
Why?
| Ileum | 1 | 2009 | 108 | 0.090 |
Why?
| CHO Cells | 2 | 2006 | 125 | 0.090 |
Why?
| Plasmids | 1 | 2009 | 180 | 0.090 |
Why?
| Cricetinae | 2 | 2006 | 211 | 0.090 |
Why?
| Spleen | 1 | 2009 | 186 | 0.080 |
Why?
| Whole-Body Irradiation | 1 | 2009 | 160 | 0.080 |
Why?
| Lipids | 1 | 2009 | 179 | 0.080 |
Why?
| Dependovirus | 1 | 2009 | 102 | 0.080 |
Why?
| Radiation Injuries, Experimental | 1 | 2009 | 124 | 0.080 |
Why?
| RNA | 1 | 2009 | 200 | 0.080 |
Why?
| CpG Islands | 1 | 2008 | 104 | 0.080 |
Why?
| Ethanol | 1 | 2010 | 319 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2014 | 925 | 0.080 |
Why?
| Chronic Disease | 1 | 2010 | 611 | 0.080 |
Why?
| Myocytes, Smooth Muscle | 1 | 2008 | 92 | 0.080 |
Why?
| Cytoprotection | 1 | 2007 | 48 | 0.080 |
Why?
| Cell Size | 1 | 2007 | 46 | 0.080 |
Why?
| Survival Analysis | 1 | 2009 | 739 | 0.080 |
Why?
| Bone Marrow | 1 | 2009 | 415 | 0.080 |
Why?
| Myocardial Reperfusion Injury | 1 | 2007 | 49 | 0.080 |
Why?
| Gene Silencing | 1 | 2007 | 127 | 0.080 |
Why?
| Nucleosomes | 1 | 2007 | 21 | 0.070 |
Why?
| Cell Count | 1 | 2007 | 181 | 0.070 |
Why?
| Scavenger Receptors, Class E | 1 | 2009 | 217 | 0.070 |
Why?
| Camptothecin | 1 | 2006 | 17 | 0.070 |
Why?
| Reactive Oxygen Species | 2 | 2015 | 494 | 0.070 |
Why?
| Acute Disease | 1 | 2008 | 405 | 0.070 |
Why?
| K562 Cells | 1 | 2006 | 47 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2006 | 132 | 0.070 |
Why?
| Uterine Cervical Neoplasms | 1 | 2009 | 276 | 0.070 |
Why?
| Breast | 1 | 2006 | 92 | 0.070 |
Why?
| Models, Molecular | 1 | 2007 | 426 | 0.070 |
Why?
| Arteriosclerosis | 1 | 2005 | 60 | 0.070 |
Why?
| Interphase | 1 | 2005 | 14 | 0.070 |
Why?
| Biotin | 1 | 2005 | 43 | 0.060 |
Why?
| Cell Hypoxia | 1 | 2004 | 89 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2007 | 1097 | 0.060 |
Why?
| Rabbits | 1 | 2005 | 440 | 0.060 |
Why?
| Glycerol | 1 | 2002 | 22 | 0.060 |
Why?
| Vesiculovirus | 1 | 2022 | 5 | 0.060 |
Why?
| Caspase Inhibitors | 1 | 2002 | 33 | 0.060 |
Why?
| Gentamicins | 1 | 2002 | 36 | 0.060 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2002 | 60 | 0.050 |
Why?
| Agriculture | 1 | 2022 | 23 | 0.050 |
Why?
| Acetaminophen | 1 | 2006 | 349 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2006 | 326 | 0.050 |
Why?
| Molecular Weight | 1 | 2002 | 104 | 0.050 |
Why?
| Plants | 1 | 2022 | 54 | 0.050 |
Why?
| Ki-67 Antigen | 1 | 2022 | 63 | 0.050 |
Why?
| Macaca mulatta | 1 | 2022 | 105 | 0.050 |
Why?
| DNA, Complementary | 1 | 2002 | 147 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2002 | 205 | 0.050 |
Why?
| Exons | 1 | 2002 | 105 | 0.050 |
Why?
| Nucleic Acid Conformation | 1 | 2002 | 99 | 0.050 |
Why?
| Sequence Alignment | 1 | 2002 | 146 | 0.050 |
Why?
| Mitochondria, Heart | 2 | 2015 | 42 | 0.050 |
Why?
| Oxygen | 1 | 2004 | 358 | 0.050 |
Why?
| Class III Phosphatidylinositol 3-Kinases | 1 | 2021 | 1 | 0.050 |
Why?
| Drosophila | 1 | 2021 | 17 | 0.050 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 277 | 0.050 |
Why?
| Hep G2 Cells | 1 | 2021 | 46 | 0.050 |
Why?
| 14-3-3 Proteins | 1 | 2021 | 22 | 0.050 |
Why?
| Base Sequence | 1 | 2002 | 732 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 5 | 0.050 |
Why?
| Female | 5 | 2014 | 28437 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2002 | 419 | 0.050 |
Why?
| Radiation | 1 | 2020 | 17 | 0.050 |
Why?
| Intestines | 1 | 2022 | 206 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2002 | 996 | 0.050 |
Why?
| Protein Biosynthesis | 1 | 2002 | 273 | 0.050 |
Why?
| Caenorhabditis elegans | 1 | 2021 | 146 | 0.050 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2020 | 215 | 0.040 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2019 | 20 | 0.040 |
Why?
| Phosphorylation | 1 | 2021 | 609 | 0.040 |
Why?
| Transcriptome | 1 | 2021 | 347 | 0.040 |
Why?
| Microbial Sensitivity Tests | 1 | 2019 | 289 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 2017 | 106 | 0.040 |
Why?
| Mitochondria | 1 | 2021 | 505 | 0.040 |
Why?
| Pyrones | 1 | 2015 | 8 | 0.030 |
Why?
| Biphenyl Compounds | 1 | 2015 | 30 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2015 | 53 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2017 | 662 | 0.030 |
Why?
| Oxidants | 1 | 2015 | 66 | 0.030 |
Why?
| Thiophenes | 1 | 2015 | 40 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2020 | 1075 | 0.030 |
Why?
| Surface Plasmon Resonance | 1 | 2014 | 25 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 78 | 0.030 |
Why?
| 5-Methylcytosine | 1 | 2014 | 18 | 0.030 |
Why?
| L-Lactate Dehydrogenase | 1 | 2014 | 84 | 0.030 |
Why?
| Spectrum Analysis, Raman | 1 | 2014 | 68 | 0.030 |
Why?
| Protein Kinase Inhibitors | 1 | 2015 | 216 | 0.030 |
Why?
| Metal Nanoparticles | 1 | 2014 | 96 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 10 | 0.030 |
Why?
| Color | 1 | 2012 | 29 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 743 | 0.030 |
Why?
| Lipoproteins | 1 | 2012 | 45 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 31 | 0.030 |
Why?
| Light | 1 | 2012 | 80 | 0.030 |
Why?
| Molecular Imaging | 1 | 2012 | 60 | 0.030 |
Why?
| Lasers | 1 | 2012 | 141 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 284 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 436 | 0.030 |
Why?
| Photoacoustic Techniques | 1 | 2012 | 86 | 0.030 |
Why?
| Interferon-beta | 1 | 2011 | 28 | 0.030 |
Why?
| Hot Temperature | 1 | 2012 | 198 | 0.030 |
Why?
| MAP Kinase Kinase 4 | 1 | 2011 | 34 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 56 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 57 | 0.020 |
Why?
| Hedgehog Proteins | 1 | 2010 | 33 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2011 | 197 | 0.020 |
Why?
| Liver Regeneration | 1 | 2010 | 57 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 255 | 0.020 |
Why?
| Enteral Nutrition | 1 | 2010 | 136 | 0.020 |
Why?
| Neoplasms | 1 | 2020 | 1309 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2010 | 193 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2010 | 195 | 0.020 |
Why?
| RNA, Neoplasm | 1 | 2009 | 55 | 0.020 |
Why?
| Parvoviridae Infections | 1 | 2009 | 20 | 0.020 |
Why?
| Middle Aged | 1 | 2005 | 13094 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2011 | 370 | 0.020 |
Why?
| Keratinocytes | 1 | 2009 | 96 | 0.020 |
Why?
| Adult | 1 | 2005 | 14196 | 0.020 |
Why?
| Extracellular Matrix Proteins | 1 | 2008 | 75 | 0.020 |
Why?
| Apoptosis Inducing Factor | 1 | 2007 | 6 | 0.020 |
Why?
| Virus Replication | 1 | 2009 | 143 | 0.020 |
Why?
| Citrate (si)-Synthase | 1 | 2007 | 12 | 0.020 |
Why?
| Cytokines | 1 | 2011 | 678 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 473 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2007 | 234 | 0.020 |
Why?
| Gene Expression | 1 | 2009 | 667 | 0.020 |
Why?
| NAD | 1 | 2006 | 46 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2005 | 41 | 0.020 |
Why?
| Necrosis | 1 | 2006 | 207 | 0.020 |
Why?
| Calcium | 1 | 2007 | 434 | 0.020 |
Why?
| Deoxyuracil Nucleotides | 1 | 2005 | 2 | 0.020 |
Why?
| Liver Diseases | 1 | 2006 | 87 | 0.020 |
Why?
| Biotinylation | 1 | 2005 | 23 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 2005 | 28 | 0.020 |
Why?
| Cricetulus | 1 | 2005 | 103 | 0.020 |
Why?
| Adenosine Triphosphate | 1 | 2006 | 253 | 0.020 |
Why?
| Glutathione | 1 | 2006 | 330 | 0.020 |
Why?
|
|
Basnakian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|